14 Treatment Strategies for Hypothalamic Hamartomas: Microsurgery versus Endoscopy
Abstract
The management and treatment of patients with hypothalamic hamartomas (HHs) has undergone rapid evolution over the past 15 years. Because of the deep location, these tumors were considered inoperable for many years. Advances in microsurgical techniques then lead to an increase in the resectability and treatment options for HH. Similarly, advances in endoscopy in neurosurgery in general opened a new avenue for treatment. This evolution is now continuing with laser interstitial therapy. There are two “open” options for resection of HH. The first is the pterional or orbitozygomatic approach. This is best for large lesions and those below the third ventricle. The second is the interhemispheric craniotomy, which takes advantage of the space between the two hemispheres of the brain to access the third ventricle. This approach is best for lesions within the third ventricle. It does not give good visualization laterally. Advances in neuroendoscopy continue to improve outcomes and decrease risk. Advanced fiberoptics allow for smaller and more flexible scopes. Devices that remove tissue have now been developed that fit down the endoscope. However, there are limitations other than tumor size and location. Endoscopy requires a ventricle that is large enough to accommodate the scope and allow visualization and working angle for the tumor. Patients with small ventricles are at higher risk of injury to the surrounding tissues. Endoscopy is also not an ideal choice for tumors that extend well below, or lateral to, the third ventricle. Neurological surgeons who specialize in microsurgical resection will continue to refine surgical techniques and remain available for the cases that prove refractory to other treatments.
14.1 Introduction
Hypothalamic hamartoma (HH) is a gray matter lesion that is nonneoplastic and generally occurs within or below the third ventricle. The most common presentations are gelastic seizures and precocious puberty. There has been some correlation between location and presenting symptoms, as lesions within the third ventricle are more likely to cause epilepsy. 1 Infrequently, lesions are large enough to cause mass effect on adjacent structures or cerebrospinal fluid (CSF) obstruction. The majority of cases are identified in childhood and careful history often reveals that the symptoms have been present since an early age, sometimes since birth. HHs have been classified according to the DeLalande classification, 2 which is based on location of attachment (▶Fig. 14.1). Since they are hamartomas, they do not grow disproportionately to brain over time.
14.2 Pathophysiology
Hypothalamic hamartoma tissue is inherently epileptogenic. Intraoperative recordings as well as single-cell in vitro recordings have demonstrated spontaneous firing from hamartoma neurons. 3 The particular types of seizures generated by this tissue are called “gelastic” and are poorly responsive to medical therapy. The morphology and attachment are variable and the location of the attachment of the HH will determine symptomatology. They have been found within the third ventricle, occupying the floor of the third ventricle or attached along the hypothalamic infundibulum. Some lesions have cysts. In large lesions, it may be difficult to determine the site of attachment, or they may appear attached to multiple regions. Lesions with purely infundibular attachments are more likely to result in precocious puberty than epilepsy. The particular interaction between hamartoma cells and cells of the hypophyseal system is not well understood.
14.3 Clinical Features
Gelastic epilepsy is the most common presenting symptom. The semiology most often involves laughter that is inappropriate, uncontrollable, and not provoked by the environment. Gelastic seizures can number in the hundreds per day and frequently last for only a few seconds. However, a constant state of seizing or “status gelasticus” has been described. 4 Many HH patients present with other seizure types and exhibit presumed secondary epileptogenesis as well. Complex partial is the most common second type of seizure.
The second category of presenting symptoms for HH is endocrine disturbance. While precocious puberty is the most common, other endocrinopathies have been seen. Diabetes insipidus has been noted before and after surgery, as well as growth hormone deficiency. Many patients with precocious puberty may be managed on a gonadotropin-releasing hormone agonist until puberty is appropriate or surgical resection is pursued.
Due to the frequent involvement of the mammillary bodies, patients will often exhibit memory deficits, and may experience declines in school function as they age. This has been considered an indication for treatment as well, as there is potential for improvement subsequently if they become seizure free. 5 Patients who exhibited the greatest degree of impairment but had the shortest duration of seizures enjoyed the most improvement.
Finally, aggressive behavior and “rage attacks” are also a common presenting symptom. Younger patients may require restraints to maintain their safety, while older patients have been institutionalized due to injury to themselves and others. Fortunately, this symptom too is very likely to improve with resection.
14.4 Diagnosis and Neuroimaging
The diagnosis of HH is typically made with magnetic resonance imaging (MRI) as HH has a characteristic imaging appearance. They are usually hyperintense on T2 and iso- to hypointense on T1 (▶Fig. 14.2 and ▶Fig. 14.3). Associated cysts are not uncommon, and there is rarely contrast enhancement. The following are the recommended MRI sequences for optimal diagnosis:
3D T1—1-mm isotropic voxels.
Sag T1—min TE; 3 mm slice, 0.5 mm gap; FOV 20 cm.
Sag T2 (FSE)—2 mm slice, no gap; FOV 20 cm.
Cor T2 (FSE)—2 mm slice, no gap; FOV 16 cm
Cor T1—3D SPGR; 2 mm slice; FOV 24 cm, recon for axial.
Axial T2 (FSE)—routine brain.
The coronal T2 sequence is best for identifying the lesion.
As mentioned, HH has been classified according to the DeLalande classification, 2 which is based on location of attachment. A correlation between the glial/neuronal fraction has been found with MR spectroscopy. Lesions with a larger glial component tended to be more hyperintense on T2. 6 Although many lesions appear to be attached bilaterally, we frequently find a true attachment only on one side with the lesion abutting the contralateral side. This detail is not always distinguishable on MRI. Unfortunately, standard functional MRI, diffusion tensor imaging, or PET scan have not provided any additional information that has changed diagnosis or management currently. Resting state MRI has more recently been useful in narrowing down the most likely site of attachment and improper signaling. 7
14.5 Indications for Intervention
The decision to intervene on a HH is individual, and team guided. Since gelastic epilepsy is poorly responsive to medical therapy, surgical resection is the best option for seizure cessation. However, many HH patients also develop other types of seizures and these other seizure types tend to be more responsive to medication than the gelastic seizures. Patients with many gelastic events per day or in whom the frequency of seizures has progressed are generally considered for surgery. Similarly, precocious puberty and other endocrine disturbances that are not responsive to medical treatment are also indications for intervention. Many patients with precocious puberty can be managed on Lupron for extended periods of time, although tolerance does occur. Finally, there is emerging evidence that patients with severe behavioral problems may improve significantly after HH resection. A series of four patients treated solely for unmanageable behavior problems (paroxysms of rage, behavior threatening others) showed dramatic improvement after surgery. 8 There are no specific contraindications to HH surgery at this time. As always, the risk of surgical intervention is carefully weighed with the family and care team.
There are a number of options for surgical intervention. These include (1) open surgery with craniotomy (interhemispheric or orbitozygomatic), (2) endoscopic resection, (3) stereotactic laser ablation (SLA), and (4) stereotactic radiosurgery. Each has their unique features and indications for use. While stereotactic radiosurgery provides a more minimally invasive treatment option, we have found that efficacy frequently requires 12 to 18 months, even up to 24 months, and some literature encourages waiting up to 3 years. 9 As a result, this modality is reserved for patients with milder or less frequent symptoms, or those who are stable with conservative therapy. As with the endoscopic approach, there is a size limitation for radiosurgery. Lesions over 3 cm are not considered suitable for treatment. Lesions that are immediately adjacent to the optic tracts or chiasm are also excluded. As a result, we will focus on open and more minimally invasive surgical techniques.